CT Discovery Platform
CURA's novel CT discovery platform harnesses the healing power of the immune system by leveraging AI predictive protein modeling, comprehensive immune functional assays, and deep domain expertise in pathway analysis to design bioengineered recombinant proteins that initiate a sequence of immune responses to combat complex diseases.
Our CT immunotherapy platform develops recombinant proteins with potent anti-metastatic, anti-fibrotic, and anti-senescent properties to address unmet medical needs.
